LGT Capital Partners’s DexCom DXCM Stock Holding History

LGT Capital Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.9M	Buy	340,670 +93,520	+38%	+$6.23M	1.16%	34
2026 Q1	$15.5M	Buy	+247,150	New	+$17.2M	0.82%	31

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

LGT Capital Partners's DXCM Position: Q2 2026 in Review

LGT Capital Partners increased its DexCom (DXCM) stake by 38% in Q2 2026, buying an estimated $6.23M and bringing the position to 340,670 shares worth $22.9M. The position accounts for 1.16% of the portfolio, ranked #34.

LGT Capital Partners first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 971 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

LGT Capital Partners held 340,670 shares of DexCom worth $22.9M as of Q2 2026.
LGT Capital Partners bought 93,520 DexCom shares in Q2 2026, an estimated $6.23M.
DexCom made up 1.16% of LGT Capital Partners's portfolio in Q2 2026, its #34 holding.
LGT Capital Partners first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
971 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on LGT Capital Partners's 13F filing for Q2 2026, filed 5 Aug 2026.